Anzeige
Meldung des Tages: Wenn Lieferketten brechen: Dieses Metall könnte zum nächsten Engpass werden

Mereo Biopharma Aktie (ADR) News

Aktie
WKN:  A2PEYJ ISIN:  US5894921072 US-Symbol:  MREO Branche:  Biotechnologie Land:  Großbritannien
0,292 €
+0,003 €
+1,04%
12:04:35 Uhr
Depot/Watchlist
Marktkapitalisierung *
1,52 Mrd. €
Streubesitz
29,08%
KGV
-8,20
Faktor
0.2
Originalaktie
GB00BZ4G2K23

Mereo Biopharma Group Aktie (ADR) News

10.03.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit PR Newswire
10.03.26 - PR Newswire
Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join - Contact The Gross Law Firm PR Newswire
06.03.26 - PR Newswire
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 PR Newswire
06.03.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit PR Newswire
05.03.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - ...
04.03.26 - PR Newswire
LEVI & KORSINSKY, LLP: CHRONOLOGY OF EVENTS IN THE MEREO BIOPHARMA SECURITIES CLASS ACTION
LEVI & KORSINSKY, LLP: CHRONOLOGY OF EVENTS IN THE MEREO BIOPHARMA SECURITIES CLASS ACTION PR Newswire
03.03.26 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo Lawsuit - MREO
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo Lawsuit - MREO PR Newswire
02.03.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
02.03.26 - PR Newswire
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO PR Newswire
27.02.26 - PR Newswire
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 PR Newswire
26.02.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit PR Newswire
26.02.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - ...
25.02.26 - PR Newswire
LEVI & KORSINSKY, LLP: MEREO BIOPHARMA SECURITIES FILINGS ALLEGEDLY CONTAINED MISLEADING CLINICAL TRIAL DISCLOSURES
LEVI & KORSINSKY, LLP: MEREO BIOPHARMA SECURITIES FILINGS ALLEGEDLY CONTAINED MISLEADING CLINICAL TRIAL DISCLOSURES PR Newswire
24.02.26 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo BioPharma Group plc Lawsuit - MREO
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo BioPharma Group plc Lawsuit - MREO PR Newswire
23.02.26 - PR Newswire
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO PR Newswire
23.02.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
20.02.26 - PR Newswire
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 PR Newswire
19.02.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - ...
18.02.26 - PR Newswire
Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately
Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately PR Newswire
18.02.26 - PR Newswire
NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline
NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline PR Newswire

Newssuche

Videos

newspaper
23.03.26 +2,04%
Technical Trading: Gold Long nach Absturz
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »